Development and validation of a pyradiomics signature to predict initial treatment response and prognosis during transarterial chemoembolization in hepatocellular carcinoma
We aimed to develop and validate a pyradiomics model for preoperative prediction of initial treatment response to transarterial chemoembolization (TACE) in patients with hepatocellular carcinoma (HCC). To this end, computed tomography (CT) images were acquired from multi-centers. Numerous pyradiomic...
Main Authors: | Jie Peng, Fangyang Lu, Jinhua Huang, Jing Zhang, Wuxing Gong, Yong Hu, Jun Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-10-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.853254/full |
Similar Items
-
Predictors of Refractoriness and Survival following Transarterial Chemoembolization for Hepatocellular Carcinoma: Outcomes from a Southeast Asian Cohort
by: Rudolf V. Kuhn, et al.
Published: (2023-12-01) -
Transarterial chemoembolization with 125I seed insertion for multifocal hepatocellular carcinoma
by: You-Bin Wang, et al.
Published: (2024-04-01) -
Cost-effectiveness analysis of drug-eluting beads and conventional transarterial chemoembolization in the treatment of hepatocellular carcinoma
by: Guoliang Shao, et al.
Published: (2022-10-01) -
Transarterial Chemoembolization in Hepatocellular Carcinoma, Albanian Experience.
by: Ilirian Laçi, et al.
Published: (2022-07-01) -
A retrospective pilot study of transarterial chemoembolisation using camrelizumab-eluting Callisphere beads for unresectable hepatocellular carcinoma
by: Xiaonan Shi, et al.
Published: (2023-11-01)